TY - JOUR
T1 - Practical recommendations for the management of diabetes in patients with COVID-19
AU - Bornstein, Stefan R.
AU - Rubino, Francesco
AU - Khunti, Kamlesh
AU - Mingrone, Geltrude
AU - Hopkins, David
AU - Birkenfeld, Andreas L.
AU - Boehm, Bernhard
AU - Amiel, Stephanie
AU - Holt, Richard IG
AU - Skyler, Jay S.
AU - DeVries, J. Hans
AU - Renard, Eric
AU - Eckel, Robert H.
AU - Zimmet, Paul
AU - Alberti, Kurt George
AU - Vidal, Josep
AU - Geloneze, Bruno
AU - Chan, Juliana C.
AU - Ji, Linong
AU - Ludwig, Barbara
PY - 2020/6
Y1 - 2020/6
N2 - Diabetes is one of the most important comorbidities linked to the severity of all three known human pathogenic coronavirus infections, including severe acute respiratory syndrome coronavirus 2. Patients with diabetes have an increased risk of severe complications including Adult Respiratory Distress Syndrome and multi-organ failure. Depending on the global region, 20–50% of patients in the coronavirus disease 2019 (COVID-19) pandemic had diabetes. Given the importance of the link between COVID-19 and diabetes, we have formed an international panel of experts in the field of diabetes and endocrinology to provide some guidance and practical recommendations for the management of diabetes during the pandemic. We aim to briefly provide insight into potential mechanistic links between the novel coronavirus infection and diabetes, present practical management recommendations, and elaborate on the differential needs of several patient groups.
AB - Diabetes is one of the most important comorbidities linked to the severity of all three known human pathogenic coronavirus infections, including severe acute respiratory syndrome coronavirus 2. Patients with diabetes have an increased risk of severe complications including Adult Respiratory Distress Syndrome and multi-organ failure. Depending on the global region, 20–50% of patients in the coronavirus disease 2019 (COVID-19) pandemic had diabetes. Given the importance of the link between COVID-19 and diabetes, we have formed an international panel of experts in the field of diabetes and endocrinology to provide some guidance and practical recommendations for the management of diabetes during the pandemic. We aim to briefly provide insight into potential mechanistic links between the novel coronavirus infection and diabetes, present practical management recommendations, and elaborate on the differential needs of several patient groups.
UR - http://www.scopus.com/inward/record.url?scp=85083785408&partnerID=8YFLogxK
U2 - 10.1016/S2213-8587(20)30152-2
DO - 10.1016/S2213-8587(20)30152-2
M3 - Review article
AN - SCOPUS:85083785408
SN - 2213-8587
VL - 8
SP - 546
EP - 550
JO - The Lancet Diabetes and Endocrinology
JF - The Lancet Diabetes and Endocrinology
IS - 6
ER -
